Diagnostic dilemma of paraneoplastic arthritis: case series

Autor: Yavuz Pehlivan, Kenan Aksu, Mehmet Soy, Ediz Dalkilic, Hakan Emmungil, Sema Yilmaz, Bunyamin Kisacik, Sedat Yilmaz, Fatma Alibaz Öner, Şule Yaşar Bilge, Haner Direskeneli, Veli Cobankara, Seval Kul, Ömer Nuri Pamuk, Rıdvan Mercan, Soner Senel, Ayten Yazici, Ahmet Mesut Onat, Mehmet Akif Ozturk, Hakan Erdem, Salim Dönmez, Şükran Erten, Cemal Bes, Mehmet Sayarlioglu, Timuçin Kaşifoğlu, Gozde Yildirim Cetin
Přispěvatelé: [Kisacik, Bunyamin -- Onat, Ahmet M. -- Pehlivan, Yavuz -- Kul, Seval] Gaziantep Univ, Fac Med, Div Rheumatol, Dept Internal Med, TR-27100 Sahinbey, Gaziantep, Turkey -- [Kasifoglu, Timucin -- Bilge, Sule Y.] Osmangazi Univ, Fac Med, Eskisehir, Turkey -- [Pamuk, Omer N. -- Donmez, Salim] Trakya Univ, Fac Med, Edirne, Turkey -- [Dalkilic, Ediz] Uludag Univ, Fac Med, Bursa, Turkey -- [Yilmaz, Sedat -- Erdem, Hakan] Gulhane Mil Med Acad, Ankara, Turkey -- [Mercan, Ridvan -- Ozturk, Mehmet A.] Gazi Univ, Fac Med, Ankara, Turkey -- [Bes, Cemal -- Soy, Mehmet] AbantIzzetBaysal Univ Med, Bolu, Turkey -- [Erten, Sukran] Ataturk Hosp, Minist Hlth, Div Rheumatol, Ankara, Turkey -- [Erten, Sukran] Dept Internal Med, Div Rheumatol, Ankara, Turkey -- [Cobankara, Veli] Pamukkale Univ, Fac Med, Ankara, Turkey -- [Senel, Soner] Cumhuriyet Univ, Fac Med, Denizli, Turkey -- [Oner, Fatma A. -- Direskeneli, Haner] Marmara Univ, Fac Med, Istanbul, Turkey -- [Yilmaz, Sema] Selcuk Univ, Selcuklu Fac Med, Konya, Turkey -- [Yazici, Ayten] Sakarya Res & Training Hosp, Div Rheumatol, Sakarya, Turkey -- [Emmungil, Hakan -- Aksu, Kenan] Ege Univ, Fac Med, Izmir, Turkey -- [Cetin, Gozde Y. -- Sayarlioglu, Mehmet] Kahramanmaras Sutcu Imam Univ, Fac Med, TR-46050 Kahramanmaras, Turkey, mercan, ridvan -- 0000-0003-1537-2192, SOY, MEHMET -- 0000-0003-1710-7018, aksu, kenan -- 0000-0001-8889-2688
Rok vydání: 2014
Předmět:
Male
Turkey
Paraneoplastic Syndromes
early rheumatoid arthritis
Arthritis
immunology
Arthritis
Rheumatoid

differential diagnosis
joint
Young adult
Oligoarthritis
predictive value
cyclic citrullinated peptide
clinical trial
Middle Aged
biological marker
Treatment Outcome
Antirheumatic Agents
Polyarthritis
Biological Markers
Female
Adult
medicine.medical_specialty
Malignancy
Early rheumatoid arthritis
Peptides
Cyclic

Diagnosis
Differential

Rheumatology
cyclopeptide
blood
Predictive Value of Tests
Rheumatoid Factor
Internal medicine
medicine
Rheumatoid factor
Humans
human
Aged
L-Lactate Dehydrogenase
business.industry
paraneoplastic arthritis
lactate dehydrogenase
case control study
medicine.disease
Paraneoplastic arthritis
multicenter study
Case-Control Studies
Immunology
antirheumatic agent
pathology
Joints
business
Biomarkers
malignancy
Zdroj: International journal of rheumatic diseases. 17(6)
ISSN: 1756-185X
0003-4436
Popis: WOS: 000344362300007
PubMed ID: 24433553
Objectives: Paraneoplastic arthritis (PA) may mimic rheumatic diseases. While presenting the demographic and laboratory features of the patients diagnosed with PA, this study also aims to provide possible appropriate tools to differentiate the PA cases from early rheumatoid arthritis (ERA). Methods: Sixty-five patients with PA (male/female: 43/22) from 15 different rheumatology clinics and 50 consecutive patients with ERA (male/female: 13/37) fulfilling the 2010 American College of Rheumatology (ACR) criteria for the diagnosis if the RA from Gaziantep Rheumatology Early Arthritis Trial (GREAT) as controls who were diagnosed at least 12 months before, were enrolled into study. Results: Mean ages of the patients with PA and ERA were 50.2 +/- 15.3, and 42.7 +/- 12.3, respectively, and the mean ages of the patients with PA were significantly higher than the ERA. Unlike the ERA patients, in our case series PA was predominantly observed among males. Oligoarthritis was significantly higher in solid tumors in contrast to ERA (P = 0.001). Polyarthritis and symmetric arthritis were significantly higher in the ERA group in contrast to all malignancies (P = 0.001). Rheumatoid factor (RF) and anticyclic citrullinated peptide antibody (anti-CCP) positivity were significantly higher in the ERA group (each P = 0.001). Lactic dehydrogenase levels of hematologic malignancies were significantly higher than other groups (each, P = 0.001). Conclusions: ERA patients had more symmetric joint involvement than PA; laboratory markers could be also an alternative where there is high RF and anti-CCP positivity with antibody levels among the ERA patients. Finally, the demographic features can be used as differentiating
Databáze: OpenAIRE